Kageshita T, Yoshii A, Kimura T, Maruo K, Ono T, Himeno M, Nishimura Y
Department of Dermatology, Kumamoto University School of Medicine, Japan.
Arch Dermatol Res. 1995;287(3-4):266-72. doi: 10.1007/BF01105077.
We carried out biochemical and immunohistochemical analyses of cathepsins B, H, L and D in human melanocytic tumours using monospecific antibodies against rat cathepsins. In Western blot analysis, anti-rat cathepsin antibodies reacted with the cathepsins from normal human tissues and human malignant melanoma. However, the molecular profiles of the cathepsins from human melanoma were slightly different from those of the rat cathepsins, suggesting a distinct intracellular processing mechanism for cathepsins in human melanoma. Although cathepsins B, H, L and D were expressed in primary and metastatic melanomas and pigmented naevi immunohistochemically, the intensity of staining in metastatic melanomas was stronger than in primary melanomas and pigmented naevi. These findings suggest that anti-rat cathepsin antibodies may be useful in biochemical and/or immunohistochemical analysis of human melanocytic tumours.
我们使用针对大鼠组织蛋白酶的单特异性抗体,对人类黑素细胞肿瘤中的组织蛋白酶B、H、L和D进行了生化和免疫组织化学分析。在蛋白质印迹分析中,抗大鼠组织蛋白酶抗体与来自正常人组织和人类恶性黑色素瘤的组织蛋白酶发生反应。然而,人类黑色素瘤中组织蛋白酶的分子谱与大鼠组织蛋白酶略有不同,这表明人类黑色素瘤中组织蛋白酶存在独特的细胞内加工机制。虽然组织蛋白酶B、H、L和D在原发性和转移性黑色素瘤以及色素痣中免疫组织化学表达,但转移性黑色素瘤中的染色强度强于原发性黑色素瘤和色素痣。这些发现表明,抗大鼠组织蛋白酶抗体可能有助于人类黑素细胞肿瘤的生化和/或免疫组织化学分析。